Table 4.
Clinical characteristics of patients omitted from original trial
Clinical finding | Placebo
|
Tenecteplase
|
||
---|---|---|---|---|
N =4 | N= 3 | |||
Obese (BMI>30 kg/m2) | 3 | 75 % | 1 | 33 % |
Active malignancy | 0 | 0 % | 0 | 0 % |
Prior history of PE or DVT | 0 | 0 % | 1 | 33 % |
Chronic obstructive pulmonary disease | 0 | 0 % | 0 | 0 % |
Heart failure | 1 | 25 % | 0 | 0 % |
Age (years, mean and SD) | 54 (7) | 71 (16) | ||
Body mass index (kg/m2) | 32 (6) | 34 (13) |
PE pulmonary embolism, DVT deep venous thrombosis, BMI body mass index, SD standard deviation